Literature DB >> 2047507

Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of parkinsonism.

K P Ebmeier1, S A Calder, J R Crawford, L Stewart, R H Cochrane, J A Besson.   

Abstract

A whole population cohort of 157 patients with idiopathic Parkinsonism, most of whom had previously been clinically examined by Mutch (1986a), were assessed to determine prevalence figures for dementia and examine the relationship between dementia, cognitive impairment and Parkinsonian signs. Dementia according to DSM-III-R criteria was diagnosed in 23.3% of all patients (95% confidence interval: 17.1 to 32.4%). Dementia and cognitive impairment were associated with overall measures of Parkinsonian impairment and rigidity, but not tremor, even after controlling for age, sex and education.

Entities:  

Mesh:

Year:  1991        PMID: 2047507     DOI: 10.1017/s0033291700014665

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

2.  The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders.

Authors:  Sharon Ash; Sharon X Xie; Rachel Goldmann Gross; Michael Dreyfuss; Ashley Boller; Emily Camp; Brianna Morgan; Jessica O'Shea; Murray Grossman
Journal:  Neuropsychology       Date:  2012-02-06       Impact factor: 3.295

3.  The organization of narrative discourse in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Brianna Morgan; Ashley Boller; Michael Dreyfuss; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-10       Impact factor: 2.381

4.  Impairments of speech fluency in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Delani Gunawardena; Brianna Morgan; Ashley Boller; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-11-17       Impact factor: 2.381

5.  Behavioral disturbances in Parkinson's disease.

Authors:  Karen E Anderson
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

6.  Hormone replacement therapy and risk for neurodegenerative diseases.

Authors:  Richelin V Dye; Karen J Miller; Elyse J Singer; Andrew J Levine
Journal:  Int J Alzheimers Dis       Date:  2012-04-04

7.  High risk of developing dementia in Parkinson's disease: a Swedish registry-based study.

Authors:  Daniel Oudin Åström; Jacob Simonsen; Lars Lau Raket; Simona Sgarbi; Johan Hellsten; Peter Hagell; Jenny M Norlin; Klas Kellerborg; Pablo Martinez-Martin; Per Odin
Journal:  Sci Rep       Date:  2022-10-06       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.